2024.04.17
Codone Biotech to Present Data on its Suppressor-tRNA Platform in Disease Models with Nonsense Mutations (Premature Termination Codons)
Shanghai, CHINA – (April 17, 2024) – Codone Biotechnology, which develops transformative medicines based on Suppressor-tRNAs for patients with severe diseases caused by nonsense mutations (aka, Premature Termination Codons), will present data on its lead tRNA candidates at the poster session for Late Breaking Abstract of the 27th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting on Wednesday, May 8, 2024.
More
